Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Myocardial InfarctionAcute Coronary SyndromeInflammationHydroxychloroquineAntirheumatic AgentsCardiovascular Diseases
Interventions
DRUG

Hydroxychloroquine

DRUG

Placebo

Trial Locations (6)

00290

Helsinki University Central Hospital, Helsinki

Unknown

North Karelia Central Hospital, Joensuu

Kymenlaakso Central Hospital, Kotka

Päijät-Häme Central Hospital, Lahti

South Karelia Central Hospital, Lappeenranta

South Ostrobotnia Central Hospital, Seinäjoki

All Listed Sponsors
collaborator

Finnish Foundation for Cardiovascular Research

OTHER

collaborator

Orion Corporation, Orion Pharma

INDUSTRY

collaborator

Aarne Koskelo Foundation

OTHER

collaborator

Finnish Cultural Foundation

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT02648464 - Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial | Biotech Hunter | Biotech Hunter